Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$18.3M |
| 2 |
WFT
Weatherford International plc
WFT
|
+$16.5M |
| 3 |
ICL Group
ICL
|
+$11.3M |
| 4 |
Liberty Media Series C
FWONK
|
+$9.18M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$6.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$23.7M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$23.5M |
| 3 |
ExxonMobil
XOM
|
+$11.1M |
| 4 |
IBM
IBM
|
+$8.88M |
| 5 |
HSH
HILLSHIRE BRANDS CO
HSH
|
+$8.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.81% |
| 2 | Technology | 13.76% |
| 3 | Energy | 11.48% |
| 4 | Industrials | 10.81% |
| 5 | Consumer Staples | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Regis Corp
RGS
$70.1M
| $1.03M | ﹤0.01% |
3,220
-65
| -2% | -$19.5K |
|
1652
Sturm, Ruger & Co
RGR
$601M
| $1.03M | ﹤0.01% |
21,100
-400
| -2% | -$21.1K |
|
1653
Novavax
NVAX
$1.34B
| $1.02M | ﹤0.01% |
12,273
-275
| -2% | -$24.9K |
|
|
LORL
1654
DELISTED
Loral Space and Communications, Inc.
LORL
| $1.02M | ﹤0.01% |
14,200
-300
| -2% | -$22.1K |
|
1655
First Financial Bancorp
FFBC
$3.6B
| $1.02M | ﹤0.01% |
64,300
-1,200
| -2% | -$19.9K |
|
1656
Insight Enterprises
NSIT
$4.6B
| $1.02M | ﹤0.01% |
45,000
-2,100
| -4% | -$55.9K |
|
|
LTXB
1657
DELISTED
LegacyTexas Financial Group Inc
LTXB
| $1.02M | ﹤0.01% |
42,500
-800
| -2% | -$20.6K |
|
|
HW
1658
DELISTED
Headwaters Inc
HW
| $1.02M | ﹤0.01% |
81,100
-1,400
| -2% | -$17.6K |
|
|
CSGS
1659
DELISTED
CSG Systems International
CSGS
| $1.01M | ﹤0.01% |
38,500
-600
| -2% | -$16.2K |
|
1660
NBT Bancorp
NBTB
$2.79B
| $1.01M | ﹤0.01% |
44,900
-900
| -2% | -$21.3K |
|
1661
ESCO Technologies
ESE
$7.79B
| $1.01M | ﹤0.01% |
29,000
-500
| -2% | -$17.4K |
|
|
MHR
1662
DELISTED
MAGNUM HUNTER RESOURCES CORP (DEL)
MHR
| $1.01M | ﹤0.01% |
180,900
| – | – |
|
|
IRC
1663
DELISTED
INLAND REAL ESTATE CORP
IRC
| $1.01M | ﹤0.01% |
101,600
-2,100
| -2% | -$21.8K |
|
|
ARNA
1664
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1M | ﹤0.01% |
23,970
-410
| -2% | -$18.3K |
|
1665
Cato Corp
CATO
$66.7M
| $1M | ﹤0.01% |
29,100
+2,300
| +9% | +$76.7K |
|
1666
Provident Financial Services
PFS
$3.26B
| $1M | ﹤0.01% |
61,300
-1,000
| -2% | -$16.9K |
|
1667
Diodes
DIOD
$4.48B
| $1M | ﹤0.01% |
41,800
-700
| -2% | -$18.5K |
|
1668
Otter Tail
OTTR
$3.9B
| $1M | ﹤0.01% |
37,500
-600
| -2% | -$17K |
|
1669
Globus Medical
GMED
$11.5B
| $999K | ﹤0.01% |
50,800
| – | – |
|
|
IMGN
1670
DELISTED
Immunogen Inc
IMGN
| $998K | ﹤0.01% |
94,200
-1,600
| -2% | -$18.1K |
|
|
BDBD
1671
DELISTED
BOULDER BRANDS INC
BDBD
| $988K | ﹤0.01% |
72,500
| – | – |
|
|
INN
1672
Summit Hotel Properties
INN
$656M
| $987K | ﹤0.01% |
91,600
-1,700
| -2% | -$18.2K |
|
1673
Intrepid Potash
IPI
$484M
| $987K | ﹤0.01% |
6,390
-110
| -2% | -$16.9K |
|
|
MOVE
1674
DELISTED
MOVE INC COM STK NEW (DE)
MOVE
| $985K | ﹤0.01% |
47,000
| – | – |
|
|
MACK
1675
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $977K | ﹤0.01% |
14,146
| – | – |
|
Similar funds
Swiss National Bank's Q3 2014 Portfolio in Review
As of Q3 2014, Swiss National Bank held 2,547 positions worth $26.1B, down 3.5% from $27B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q3 2014: portfolio turnover was 1.3%. Swiss National Bank opened 15 new positions and exited 18, leaving the 2,547-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Energy.
- Swiss National Bank's largest Q3 2014 buy was Weatherford International plc: 735,946 shares worth $15.3M.
- Swiss National Bank added most to Allergan plc in Q3 2014, an estimated $18.3M increase.
- Swiss National Bank's biggest Q3 2014 reduction was Apple, cutting an estimated $23.7M.
- Swiss National Bank fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $23.5M.
- Swiss National Bank's ten largest holdings make up 14% of its $26.1B portfolio in Q3 2014.
- Swiss National Bank opened 15 new positions and closed 18 in Q3 2014.
- Swiss National Bank's portfolio value fell 3.5% quarter-over-quarter to $26.1B.
Based on Swiss National Bank's 13F filing for Q3 2014, filed 4 Nov 2014.